VistaGen Therapeutics, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUTING FIRM - June 24, 2016

Attached files

file filename
EX-31.1 - CERTIFICATION OF THE COMPANY'S CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - VistaGen Therapeutics, Inc.ex31-1.htm
10-K - ANNUAL REPORT - VistaGen Therapeutics, Inc.vsta10k_mar312016.htm
EX-32.1 - CERTIFICATION OF THE COMPANY'S CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - VistaGen Therapeutics, Inc.ex32-1.htm
EX-31.2 - CERTIFICATION OF THE COMPANY'S CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - VistaGen Therapeutics, Inc.ex31-2.htm
EX-10.117 - SECOND AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN VISTAGEN THERAPEUTICS, INC. AND H. RALPH SNODGRASS, PH.D., - VistaGen Therapeutics, Inc.ex10-117.htm
EX-10.116 - SECOND AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN VISTAGEN THERAPEUTICS, INC. AND SHAWN K. SINGH - VistaGen Therapeutics, Inc.ex10-116.htm
EX-10.112 - INDEMNIFICATION AGREEMENT EFFECTIVE APRIL 8, 2016 BETWEEN THE COMPANY AND JERRY B. GIN - VistaGen Therapeutics, Inc.ex10-112.htm
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-208354) of VistaGen Therapeutics, Inc. of our report dated June 24, 2016, relating to the consolidated financial statements of VistaGen Therapeutics, Inc., which appears in this Annual Report on Form 10-K.

/s/ OUM & CO. LLP

San Francisco, California
June 24, 2016

 

VistaGen Therapeutics, Inc. Reports